Biotech IPOs: Lessons on How a Company Manages to Succeed After Failure


The following post was published on the Knowledge@Wharton website on January 22, 2014. The data is in, and there is no question that 2013 was the most active year for biotechnology initial public...

Intercept Pharma Continues Epic Stock Surge After Thursday Blockbuster


Fresh off Thursday’s amazing 280% stock pop, Intercept Pharmaceuticals defied gravity again on Friday, surging another 50% in morning trading. Intercept is flying high after positive results on a ...